Basic Information
| RNALocate ID: | RLID:11000992 |
| RNA Symbol: | hsa-miR-99a-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-99a |
| RNA ID: | miRBase:MIMAT0000097 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23539611 |
| Tissue/Cell Line: | Seminal plasma |
| Method: | Microarray |
| Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001425 | Cytoplasm | Neural progenitor cells | 21363885 |
| RLID:01001426 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001427 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001428 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001429 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001430 | Nucleolus | Breast adenocarcinoma cells (MCF-7) | 24918059 |
| RLID:11000987 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11000988 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
| RLID:11000989 | Exosome | Primary dendritic cells | 21505438 |
| RLID:11000990 | Exosome | Plasma | 23663360 |
| RLID:11000991 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID-D:11000031 | Exosome | Blood|Breast milk|Chronic lymphocytic leukemia cells|Endothelial cells|Lymphoma tissue|Seminal fluid | |
| RLID-D:11000296 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-99a-5p | Diffuse large b cell lymphoma | MNDR-E-MI-73041 |
| MNDR | hsa-miR-99a-5p | Splenic marginal zone lymphoma | MNDR-E-MI-73042 |
| MNDR | hsa-miR-99a-5p | Oral squamous cell carcinoma | MNDR-E-MI-73043 |
| MNDR | hsa-miR-99a-5p | Large cell neuroendocrine cancer | MNDR-E-MI-73044 |
| MNDR | hsa-miR-99a-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-73045 |
| MNDR | hsa-miR-99a-5p | Ovarian clear cell carcinoma | MNDR-E-MI-73046 |
| MNDR | hsa-miR-99a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-73047 |
| MNDR | hsa-miR-99a-5p | Lymphoma | MNDR-E-MI-73048 |
| MNDR | hsa-miR-99a-5p | Lymphoma non-hodgkin | MNDR-E-MI-73049 |
| MNDR | hsa-miR-99a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-73050 |
| MNDR | hsa-miR-99a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-73051 |
| MNDR | hsa-miR-99a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-73052 |
| MNDR | hsa-miR-99a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-73053 |
| MNDR | hsa-miR-99a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-73054 |
| MNDR | hsa-miR-99a-5p | Breast cancer luminal | MNDR-E-MI-73055 |
| MNDR | hsa-miR-99a-5p | Niemann-pick disease type c | MNDR-E-MI-73056 |
| MNDR | hsa-miR-99a-5p | Dermatomyositis | MNDR-E-MI-73057 |
| MNDR | hsa-miR-99a-5p | Prostate cancer | MNDR-E-MI-73058 |
| MNDR | hsa-miR-99a-5p | Gastric cancer | MNDR-E-MI-73059 |
| MNDR | hsa-miR-99a-5p | Gastric lymphoma | MNDR-E-MI-73060 |
| MNDR | hsa-miR-99a-5p | Alzheimer disease | MNDR-E-MI-73061 |
| MNDR | hsa-miR-99a-5p | Intracranial aneurysm | MNDR-E-MI-73062 |
| MNDR | hsa-miR-99a-5p | Bladder cancer | MNDR-E-MI-73063 |
| MNDR | hsa-miR-99a-5p | Esophageal carcinoma | MNDR-E-MI-73064 |
| MNDR | hsa-miR-99a-5p | Dysautonomia familial | MNDR-E-MI-73065 |
| MNDR | hsa-miR-99a-5p | Seizures | MNDR-E-MI-73066 |
| MNDR | hsa-miR-99a-5p | Head and neck cancer | MNDR-E-MI-73067 |
| MNDR | hsa-miR-99a-5p | Leukemia | MNDR-E-MI-73068 |
| MNDR | hsa-miR-99a-5p | Ataxia telangiectasia | MNDR-E-MI-73069 |
| MNDR | hsa-miR-99a-5p | Cardiovascular disease | MNDR-E-MI-73070 |
| MNDR | hsa-miR-99a-5p | Lung cancer | MNDR-E-MI-73071 |
| MNDR | hsa-miR-99a-5p | Down syndrome | MNDR-E-MI-73072 |
| MNDR | hsa-miR-99a-5p | Parkinson disease | MNDR-E-MI-73073 |
| MNDR | hsa-miR-99a-5p | Niemann-pick disease | MNDR-E-MI-73074 |
| MNDR | hsa-miR-99a-5p | Basal-like breast cancer | MNDR-E-MI-73075 |
| MNDR | hsa-miR-99a-5p | Neuroendocrine neoplasia | MNDR-E-MI-73076 |
| MNDR | hsa-miR-99a-5p | Pancreatic cancer | MNDR-E-MI-73077 |
| MNDR | hsa-miR-99a-5p | Melanoma | MNDR-E-MI-73078 |
| MNDR | hsa-miR-99a-5p | Lesch-nyhan syndrome | MNDR-E-MI-73079 |
| MNDR | hsa-miR-99a-5p | Hepatitis B | MNDR-E-MI-73080 |
| MNDR | hsa-miR-99a-5p | Colon cancer | MNDR-E-MI-73081 |
| MNDR | hsa-miR-99a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-73082 |
| MNDR | hsa-miR-99a-5p | Ovarian cancer | MNDR-E-MI-73083 |
| MNDR | hsa-miR-99a-5p | Prostate adenocarcinoma | MNDR-E-MI-73084 |
| MNDR | hsa-miR-99a-5p | Carcinoma ductal breast | MNDR-E-MI-73085 |
| MNDR | hsa-miR-99a-5p | Glioblastoma | MNDR-E-MI-73086 |
| MNDR | hsa-miR-99a-5p | Glioma | MNDR-E-MI-73087 |
| MNDR | hsa-miR-99a-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-73088 |
| MNDR | hsa-miR-99a-5p | Chordoma | MNDR-E-MI-73089 |
| MNDR | hsa-miR-99a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-73090 |
| MNDR | hsa-miR-99a-5p | Epilepsy temporal lobe | MNDR-E-MI-73091 |
| MNDR | hsa-miR-99a-5p | Osteosarcoma | MNDR-E-MI-73092 |
| MNDR | hsa-miR-99a-5p | Inclusion body myositis | MNDR-E-MI-73093 |
| MNDR | hsa-miR-99a-5p | Breast carcinoma | MNDR-E-MI-73094 |
| MNDR | hsa-miR-99a-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-73095 |
| MNDR | hsa-miR-99a-5p | Meningioma | MNDR-E-MI-73096 |
| MNDR | hsa-miR-99a-5p | Uterine cancer | MNDR-E-MI-73097 |
| MNDR | hsa-miR-99a-5p | Cervical adenocarcinoma | MNDR-E-MI-73098 |
| MNDR | hsa-miR-99a-5p | Gastric adenocarcinoma | MNDR-E-MI-73099 |
| MNDR | hsa-miR-99a-5p | Cervical squamous cell carcinoma | MNDR-E-MI-73100 |
| MNDR | hsa-miR-99a-5p | Lung squamous cell carcinoma | MNDR-E-MI-73101 |
| MNDR | hsa-miR-99a-5p | Lung adenocarcinoma | MNDR-E-MI-73102 |
| MNDR | hsa-miR-99a-5p | Adrenocortical cancer | MNDR-E-MI-73103 |
| MNDR | hsa-miR-99a-5p | Thyroid carcinoma | MNDR-E-MI-73104 |
| MNDR | hsa-miR-99a-5p | Ovarian carcinoma | MNDR-E-MI-73105 |
| MNDR | hsa-miR-99a-5p | Bladder urothelial carcinoma | MNDR-E-MI-73106 |
| MNDR | hsa-miR-99a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-73107 |
| MNDR | hsa-miR-99a-5p | Brain stem cancer | MNDR-E-MI-73108 |
| MNDR | hsa-miR-99a-5p | Carcinoma renal cell | MNDR-E-MI-73109 |
| MNDR | hsa-miR-99a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-73110 |
| MNDR | hsa-miR-99a-5p | Clear cell renal cell carcinoma | MNDR-E-MI-73111 |
| MNDR | hsa-miR-99a-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-73112 |
| MNDR | hsa-miR-99a-5p | Cholangiocarcinoma | MNDR-E-MI-73113 |
| MNDR | hsa-miR-99a-5p | Esophageal cancer | MNDR-E-MI-73114 |
| MNDR | hsa-miR-99a-5p | Liver cirrhosis | MNDR-E-MI-73115 |
| MNDR | hsa-miR-99a-5p | Lung small cell carcinoma | MNDR-E-MI-73116 |
| MNDR | hsa-miR-99a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-73117 |
| MNDR | hsa-miR-99a-5p | T acute lymphoblastic leukemia | MNDR-E-MI-73118 |
| MNDR | hsa-miR-99a-5p | Acute t cell leukemia | MNDR-E-MI-73119 |
| MNDR | hsa-miR-99a-5p | Breast invasive carcinoma | MNDR-E-MI-73120 |
| MNDR | hsa-miR-99a-5p | Early hepatocellular carcinoma | MNDR-E-MI-73121 |
| MNDR | hsa-miR-99a-5p | B-cell lymphoma | MNDR-E-MI-73122 |
| MNDR | hsa-miR-99a-5p | Rheumatoid arthritis | MNDR-E-MI-73123 |
| MNDR | hsa-miR-99a-5p | T-cell leukemia | MNDR-E-MI-73124 |
| MNDR | hsa-miR-99a-5p | Neuroblastoma | MNDR-E-MI-73125 |
| MNDR | hsa-miR-99a-5p | Barrett's adenocarcinoma | MNDR-E-MI-73126 |
| MNDR | hsa-miR-99a-5p | Hodgkin lymphoma | MNDR-E-MI-73127 |
| MNDR | hsa-miR-99a-5p | Burkitt lymphoma | MNDR-E-MI-73128 |
| MNDR | hsa-miR-99a-5p | Psoriasis | MNDR-E-MI-73129 |
| MNDR | hsa-miR-99a-5p | Acute myelocytic leukemia | MNDR-E-MI-73130 |
| MNDR | hsa-miR-99a-5p | Colorectal cancer | MNDR-E-MI-73131 |
| MNDR | hsa-miR-99a-5p | Nasopharynx carcinoma | MNDR-E-MI-73132 |
| MNDR | hsa-miR-99a-5p | Multiple myeloma | MNDR-E-MI-73133 |
| MNDR | hsa-miR-99a-5p | Ovarian epithelial cancer | MNDR-E-MI-73134 |
| MNDR | hsa-miR-99a-5p | Esophageal squamous cell carcinoma | MNDR-E-MI-73135 |
| MNDR | hsa-miR-99a-5p | Nasopharyngeal cancer | MNDR-E-MI-73136 |
| MNDR | hsa-miR-99a-5p | Sleep deprivation | MNDR-E-MI-73137 |
| MNDR | hsa-miR-99a-5p | Epstein-barr virus infections | MNDR-E-MI-73138 |
| MNDR | hsa-miR-99a-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-73139 |
| MNDR | hsa-miR-99a-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-73140 |
| MNDR | hsa-miR-99a-5p | Pancreatitis chronic | MNDR-E-MI-73141 |
| MNDR | hsa-miR-99a-5p | Stroke lacunar | MNDR-E-MI-73142 |
| MNDR | hsa-miR-99a-5p | Barrett's carcinogenesis | MNDR-E-MI-73143 |
| MNDR | hsa-miR-99a-5p | Breast cancer her3+ negative | MNDR-E-MI-73144 |
| MNDR | hsa-miR-99a-5p | Duke C | MNDR-E-MI-73145 |
| MNDR | hsa-miR-99a-5p | High grade dysplastic nodule | MNDR-E-MI-73146 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AGO2 | Homo sapiens | RR00055719 |
TOP